EFFECT OF BASELINE SERUM CRP LEVELS ON CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH FILGOTINIB: POST-HOC ANALYSIS FROM TWO PHASE 2B STUDIES

被引：0
|
作者：
Westhovens, R. [1 ]
Kavanaugh, A. [2 ]
Jamoul, C. [3 ]
Tasset, C. [3 ]
Harrison, P. [3 ]
Van der Aa, A. [3 ]
机构：
[1] Katholieke Univ Leuven, Univ Hosp, Rheumatol, Leuven, Belgium
[2] Univ Calif, La Jolla, CA USA
[3] Galapagos NV, Mechelen, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5428
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0229
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] No Effect of Baseline Serum CRP Levels on Clinical Efficacy Parameters in Rheumatoid Arthritis Patients Treated with Filgotinib: Post Hoc Analysis from Two Phase 2B Studies
    Kavanaugh, Arthur
    Van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    Westhovens, Rene
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study
    Westhovens, Rene
    van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Association between Clinical Response and Normalization of Patient-Reported Outcome Measures in Rheumatoid Arthritis: Post-Hoc Analysis from Two Phase 2b Filgotinib Studies
    Genovese, Mark C.
    Van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    Westhovens, Rene
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, P.
    Downie, B.
    Liu, J.
    Hawtin, R.
    Curtis, J. R.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 502 - 502
  • [5] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, Paul
    Downie, Bryan
    Liu, Jinfeng
    Hawtin, Rachael E.
    Curtis, Jeffrey R.
    Burmester, Gerd R.
    RHEUMATOLOGY, 2022, 61
  • [6] Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Haaland, Derek
    Hall, Stephen
    Inanc, Nevsun
    Li, Zhanguo
    Xavier, Ricardo M. M.
    Cara, Carlos
    Tilt, Nicola
    Taylor, Peter C. C.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (07) : 1248 - 1259
  • [7] BARICITINIB EFFICACY IN MODERATE RHEUMATOID ARTHRITIS - A POST-HOC ANALYSIS FROM TWO PHASE III TRIALS
    Kirkham, Bruce W.
    Nikiphorou, Elena
    Edwards, Christopher J.
    Sheesh, Mohamed
    Haladyj, Ewa
    Gerwien, Jens
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    RHEUMATOLOGY, 2023, 62
  • [8] HEPATITIS B VIRUS REACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BARICITINIB: POST-HOC ANALYSIS FROM CLINICAL TRIALS
    Harigai, M.
    Winthrop, K.
    Takeuchi, T.
    Hsieh, T. -Y.
    Chen, Y. -M.
    Smolen, J. S.
    Burmester, G. R.
    Walls, C.
    Wu, W. -S.
    Dickson, C.
    Liao, R.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 584 - 585
  • [9] Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies
    Schreiber, S.
    Loftus, E. V., Jr.
    Maaser, C.
    Danese, S.
    Rudolph, C.
    Jongen, R.
    De Haas, A.
    Oortwijn, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I085 - I087
  • [10] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY AGE: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION AND SELECTIONLTE STUDIES
    Schreiber, Stefan
    Loftus, Edward V.
    Maaser, Christian
    Danese, Silvio
    Rudolph, Christine
    Jongen, Rob
    de Haas, Angela
    Oortwijn, Alessandra
    Vermeire, Severine
    GASTROENTEROLOGY, 2022, 162 (07) : S633 - S634
12345